AgenoLab

AgenoLab is a German biotechnology company and Contract Development and Manufacturing Organization (CDMO) specializing in Advanced Therapy Medicinal Products (ATMPs). Based in Stuttgart, the company provides end-to-end services for the development and manufacturing of cell and gene therapies, with a particular focus on CAR-T cell technologies. AgenoLab offers expertise in process development, clinical manufacturing under GMP conditions, and comprehensive quality control. Their mission is to accelerate the transition of innovative cell therapies from the laboratory to clinical application. The company serves as a strategic partner for biotech firms and academic institutions looking to scale their therapeutic candidates for clinical trials. By providing specialized infrastructure and regulatory support, AgenoLab helps clients navigate the complexities of bringing next-generation biologics to market.